Parsippany, NJ (May 27, 2005) – Data from two clinical studies presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting (ASH 2005) in San Francisco demonstrated that ...
New York, NY - The FDA has approved Benicar® (olmesartan), a new angiotensin II inhibitor, for the treatment of hypertension, according to Forest Laboratories, Inc, the drug's US co-promotion partner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results